SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity
Press Releases
SEKISUI DIAGNOSTICS, LLC  
November 14, 2024

SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity

Growth of UK facility will enable clinical-grade manufacturing of drug substances for range of biopharmaceutical products

avatar profile Olean Times Herald

Olean Times Herald


Local & Social